ViOptix spies $895K to measure tissue oxygen
ViOptix, maker of a device that measures tissue oxygen levels for various medical applications, has brought in $895,000 in equity and debt, according to a filing with the SEC. Last December, during an especially tough time for biotech companies, it successfully raised $4.4 million, closing its fourth round of financing at $16.6 million.
The Fremont, Calif. company is funded by Canadian Medical Discoveries Fund, Channel Medical Partners and Morningside Technology Ventures, BioAsia Management and Lincoln Funds International.
Next Story: Facebook revs up sharing features to become a content hub
Previous Story: Tioga Energy captures $1M to broker solar power purchase agreements
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.